Evidence supporting the use of: Immunoglobulin
For the health condition: Meningitis
Synopsis
Source of validity: Scientific
Rating (out of 5): 3
Immunoglobulin (IVIG) is used as an adjunctive therapy in certain cases of meningitis, particularly in scenarios involving immunodeficiency or when meningitis is caused by specific pathogens such as enteroviruses or in cases of recurrent or chronic meningitis. The scientific rationale for its use lies in the immunomodulatory effects of IVIG, which can neutralize pathogens, modulate inflammatory responses, and provide passive immunity, especially in patients with impaired humoral immunity (such as those with agammaglobulinemia or hypogammaglobulinemia). Several case reports and small clinical studies suggest that IVIG may be beneficial in treating enteroviral meningitis in immunocompromised hosts, where lack of endogenous antibody production leads to prolonged or severe disease. However, there is limited high-quality evidence supporting routine use of immunoglobulin for bacterial or viral meningitis in immunocompetent patients, and guidelines do not recommend its use for uncomplicated cases. The overall evidence is moderate for immunocompromised patients but weak for the general population. Thus, IVIG's use in meningitis is scientifically justified in select, mainly immunodeficient, populations, but not as a universal treatment.
Other health conditions supported by immunoglobulin
Autoimmune DisordersBlood Poisoning
Cancer Treatment (reducing side effects)
Chemotherapy (reducing side effects)
Contagious Diseases
Hepatitis
Infection
Infection (bacterial)
Infection (viral)
Inflammation
Influenza
Lupus
Lymphoma
Meningitis
Myasthenia Gravis
Pneumonia
Staph Infections
Wounds and Sores